ELI LILLY & Co — Director's Dealing 2025

Aug 13, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-08-13

Reporting Person: Van Naarden Jacob (EVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-13	Common Stock	P	1000	$647.36	Acquired	20561.985	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4342	Indirect
Common Stock	4302	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.